Nasdaq Stockholm AB: New equity right for trading, Episurf Medical AB TO 13

At the request of Episurf Medical AB , Episurf Medical AB equity rights will be
traded on First North Growth Market as from June 28, 2024. 



Security name: Episurf Medical AB TO 13
----------------------------------------
Short name:   EPIS TO 13 B      
----------------------------------------
ISIN code:   SE0022060927      
----------------------------------------
Orderbook ID:  341892         
----------------------------------------

Terms:   Issue price, SEK 0.24 per share. One (1) option rights gives the  
       right to subscribe for One (1) new B-share in Episurf Medical AB  
       (publ).                              
--------------------------------------------------------------------------------
Subscripti February 10, 2025-February 24, 2025                 
on period:                                   
--------------------------------------------------------------------------------
Last    February 20, 2025                          
 trading                                    
 day:                                      
--------------------------------------------------------------------------------



For further information concerning this exchange notice please contact Issuer
Surveillance, telephone +46 8 405 70 50, or iss@nasdaq.com 

Nasdaq Stockholm AB

5 heiße Wetten für den Jahresendspurt!

Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Hier klicken

Zeit	Aktuelle Nachrichten
11.11.	Episurf Medical to present at Redeye Medtech & Diagnostics Event on November 13th, 2024
25.10.	Episurf Medical AB: Interim Report 1 January - 30 September 2024	Improvement of financial result through lower cost base and increased revenues Focus towards expansion of US sales force Continued progress of 510(k)-process for great toe implant "I am pleased... ► Artikel lesen
01.10.	Members of the Nomination Committee for Episurf Medical's Annual General Meeting in 2025
24.09.	Niles Noblitt, through Sacajo Investments LLC, makes investment in Episurf through an arrangement with CEO Pål Ryfors
24.09.	Episurf Medical: Update on 510(k) application for big toe implant

Zeit

Aktuelle Nachrichten

11.11.

Episurf Medical to present at Redeye Medtech & Diagnostics Event on November 13th, 2024

25.10.

Episurf Medical AB: Interim Report 1 January - 30 September 2024

Improvement of financial result through lower cost base and increased revenues Focus towards expansion of US sales force Continued progress of 510(k)-process for great toe implant "I am pleased...
► Artikel lesen

01.10.

Members of the Nomination Committee for Episurf Medical's Annual General Meeting in 2025

24.09.

Niles Noblitt, through Sacajo Investments LLC, makes investment in Episurf through an arrangement with CEO Pål Ryfors

24.09.

Episurf Medical: Update on 510(k) application for big toe implant

	Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Xetra-Orderbuch


	Fonds	Kurs	%


	Devisen	Kurs	%


	Rohstoffe	Kurs	%


	Themen	Kurs	%



Erweiterte Suche

EPISURF MEDICAL AB

Nasdaq Stockholm AB: New equity right for trading, Episurf Medical AB TO 13